You are here

AusPAR: Inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

2 December 2020
AusPAR Details
AusPAR
Active Ingredient
Inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin
Product Name
Fluzone High-Dose Quadrivalent
Sponsor
Sanofi-Aventis Pty Ltd
Submission Number
PM-2019-03202-1-2
Submission Type
New biological entity
Decision
Approved
AusPAR Date
27 November 2020
Publication Date

2 December 2020